Ballicules.com

Tamoxifen and Estradiol: an Estrogen receptor alpha in breast tissue interaction

Tamoxifen occupies the estrogen receptor alpha in breast tissue but activates it only partly, so beside a full agonist like Estradiol it behaves as a brake.

Estradiol is a full agonist at the estrogen receptor alpha in breast tissue. Tamoxifen binds the same receptor but produces a submaximal response however much of it is present. On an unoccupied receptor it acts; on a receptor already driven by Estradiol it displaces that fuller signal and the net effect falls.

Given together they work against whatever each was started for. If both are genuinely needed, expect less of Estradiol’s effect than its dose would suggest.

This is a pharmacodynamic interaction. Neither drug changes the other’s concentration, so a level, an AUC estimate or a genotype looks entirely normal while the clinical effect is blunted.

The direction can be the useful one. The same opposition is what makes a reversal agent, an antidote or a planned antagonist work.

Tamoxifen versus Estradiol over the Estrogen receptor alpha in breast tissue
Fight club: Tamoxifen versus Estradiol — Estrogen receptor alpha in breast tissue

The two ballicules, with the Estrogen receptor alpha in breast tissue lit on each

Tamoxifen ballicule, with its Estrogen receptor alpha in breast tissue peg ringed
Tamoxifen (NOLVADEX)
Estrogen receptor alpha in breast tissue partial agonist
Estradiol ballicule, with its Estrogen receptor alpha in breast tissue peg ringed
Estradiol (ESTRACE)
Estrogen receptor alpha in breast tissue agonist

The ring marks the peg each drug wears for this receptor — the same cross-illumination Interact! draws when the two are put side by side.

The mascots

Tamoxifen mascot mnemonic cartoon
Tamoxifen
Tame ox defends Novel Rolodex
Estradiol mascot mnemonic cartoon
Estradiol
Es-trojan horse

Open it in the console